Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Nikkho, SM; Richter, MJ; Shen, E; Abman, SH; Antoniou, K; Chung, J; Fernandes, P; Hassoun, P; Lazarus, HM; Olschewski, H; Piccari, L; Psotka, M; Saggar, R; Shlobin, OA; Stockbridge, N; Vitulo, P; Vizza, CD; Wort, SJ; Nathan, SD.
Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension
PULM CIRC. 2022; 12(3): e12127
Doi: 10.1002/pul2.12127
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Olschewski Horst
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Pulmonary hypertension (PH) has been linked to worse outcomes in chronic lung diseases. The presence of PH in the setting of underlying Interstitial Lung Disease (ILD) is strongly associated with decreased exercise and functional capacity, an increased risk of hospitalizations and death. Examining the scope of this issue and its impact on patients is the first step in trying to define a roadmap to facilitate and encourage future research in this area. The aim of our working group is to strengthen the communities understanding of PH due to lung diseases and to improve the care and quality of life of affected patients. This introductory statement provides a broad overview and lays the foundation for further in-depth papers on specific topics pertaining to PH-ILD.
- Find related publications in this database (Keywords)
- epidemiology
- interstitial lung disease
- prognosis
- pulmonary hypertension
- symptom assessment and management